CTLA-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Antczak, Adam ^a   Pastuszak Lewandoska, Dorota ^a   Górski, Paweł ^a   Domańska, Daria ^a   Migdalska Sȩk, Monika ^a   Czarnecka, Karolina ^a   Nawrot, Ewa ^a   Kordiak, Jacek ^a   Brzeziańska, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CD27 ANTIGEN;

ADULT; AGED; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CANCER SIZE; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; NON SMALL CELL LUNG CANCER;

AGED; ALLELES; ANTIGENS, CD27; CARCINOMA, NON-SMALL-CELL LUNG; CTLA-4 ANTIGEN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84880890942     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/576486     Document Type: Article

References (45)

1. Chew V., Toh H. C., Abastado J. P., Immune microenvironment in tumor progression: characteristics and challenges for therapy. Journal of Oncology 2012 2012 608406 608415
2. Tsiatas M. L., Gyftaki R., Liacos C., Politi E., Rodolakis A., Dimopoulos M.-A., Bamias A., Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy. International Journal of Gynecological Cancer 2009 19 8 1329 1334 2-s2.0-73349114891 10.1111/IGC.0b013e3181b7a40e
3. Frey A. B., Monu N., Signaling defects in anti-tumor T cells. Immunological Reviews 2008 222 1 192 205 2-s2.0-41149109745 10.1111/j.1600-065X. 2008.00606.x (Pubitemid 351430368)
4. Sharpe A. H., Abbas A. K., T-cell costimulation-biology, therapeutic potential, and challenges. The New England Journal of Medicine 2006 355 10 973 975 2-s2.0-33748428203 10.1056/NEJMp068087 (Pubitemid 44343539)
5. Nagorsen D., Scheibenbogen C., Marincola F. M., Letsch A., Keilholz U., Natural T cell immunity against cancer. Clinical Cancer Research 2003 9 12 4296 4303 2-s2.0-0141960452 (Pubitemid 37248383)
6. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited. Annual Review of Immunology 2005 23 515 548 2-s2.0-17644425689 10.1146/annurev.immunol.23.021704.115611 (Pubitemid 40563179)
7. Egen J. G., Kuhns M. S., Allison J. P., CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nature Immunology 2002 3 7 611 618 2-s2.0-0036301503 10.1038/ni0702-611 (Pubitemid 34752469)
8. Contardi E., Palmisano G. L., Tazzari P. L., Martelli A. M., Falà F., Fabbi M., Kato T., Lucarelli E., Donati D., Polito L., Bolognesi A., Ricci F., Salvi S., Gargaglione V., Mantero S., Alberghini M., Ferrara G. B., Pistillo M. P., CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. International Journal of Cancer 2005 117 4 538 550 2-s2.0-27144458821 10.1002/ijc.21155 (Pubitemid 41504541)
9. Li X., Zhang C., Zhang J., Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis. Journal of Clinical Immunology 2012 32 3 530 539
10. Pastuszak-Lewandoska D., Sewerynek E., Domańska D., CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis). Archives of Medical Science 2012 8 3 415 421
11. Tang S. T., Tang H. Q., Zhang Q., Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a meta-analysis. Gene 2012 508 2 165 187
12. Benmansour J., Stayoussef M., Al-Jenaidi F. A., Rajab M. H., Rayana C. B., Said H. B., Mahjoub T., Almawi W. Y., Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clinical and Vaccine Immunology 2010 17 9 1473 1477 2-s2.0-77956420229 10.1128/CVI.00099-10
13. Zaletel K., Krhin B., Gaberšček S., Biček A., Pajič T., Hojker S., Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis. Clinical and Experimental Immunology 2010 161 1 41 47 2-s2.0-77953246769 10.1111/j.1365-2249.2010.04113.x
14. Kavvoura F. K., Akamizu T., Awata T., Ban Y., Chistiakov D. A., Frydecka I., Ghaderi A., Gough S. C., Hiromatsu Y., Ploski R., Wang P.-W., Ban Y., Bednarczuk T., Chistiakova E. I., Chojm M., Heward J. M., Hiratani H., Juo S.-H. H., Karabon L., Katayama S., Kurihara S., Liu R.-T., Miyake I., Omrani G.-H. R., Pawlak E., Taniyama M., Tozaki T., Ioannidis J. P. A., Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 8 3162 3170 2-s2.0-34547803346 10.1210/jc.2007-0147 (Pubitemid 47240945)
15. Lee Y. H., Harley J. B., Nath S. K., CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Human Genetics 2005 116 5 361 367 2-s2.0-17144378972 10.1007/s00439-004-1244-1 (Pubitemid 40521112)
16. Karabon L., Pawlak E., Tomkiewicz A., Jedynak A., Passowicz-Muszynska E., Zajda K., Jonkisz A., Jankowska R., Krzakowski M., Frydecka I., CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer. Human Immunology 2011 72 10 947 954 2-s2.0-80052964550 10.1016/j.humimm.2011.05.010
17. Wang W., Wang J., Song H., Liu J., Song B., Cao X., Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma. Genetic Testing and Molecular Biomarkers 2011 15 7-8 503 506 2-s2.0-79960448449 10.1089/gtmb.2010.0264
18. Zheng J., Yu X., Jiang L., Xiao M., Bai B., Lu J., Zhou Y., Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis. BMC Cancer 2010 10 article 522 2-s2.0-77957261797 10.1186/1471-2407-10-522
19. Zhang Y., Zhang J., Deng Y., Tian C., Li X., Huang J., Fan H., Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Cancer 2011 117 18 4312 4324 2-s2.0-80052469506 10.1002/cncr.25979
20. Siegel R., Naishadham D., Jemal A., Cancer statistics. CA: A Cancer Journal for Clinicians 2013 63 1 11 30
21. Capece D., Verzella D., Fischietti M., Zazzeroni F., Alesse E., Targeting costimulatory molecules to improve antitumor immunity. Journal of Biomedicine and Biotechnology 2012 2012 17 2-s2.0-84858124795 10.1155/2012/926321 926321
22. Facciabene A., Motz G. T., Coukos G., T-Regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Research 2012 72 9 2162 2171 2-s2.0-84860507700 10.1158/0008-5472.CAN-11-3687
23. Mao H., Zhang L., Yang Y., Zuo W., Bi Y., Gao W., Deng B., Sun J., Shao Q., Qu X., New insights of CTLA-4 into its biological function in breast cancer. Current Cancer Drug Targets 2010 10 7 728 736 2-s2.0-78649237729
24. Zheng H., Li Y., Wang X., Zhang X., Wang X., Expression and significance of gp96 and immune-related gene CTLA-4, CD8 in lung cancer tissues. The Chinese Journal of Lung Cancer 2010 13 8 790 794 2-s2.0-78049412696 10.3779/j.issn.1009- 3419.2010.08.08
25. Shah K. V., Chien A. J., Yee C., Moon R. T., CTLA-4 is a direct target of Wnt/ β -catenin signaling and is expressed in human melanoma tumors. Journal of Investigative Dermatology 2008 128 12 2870 2879 2-s2.0-57349099365 10.1038/jid.2008.170
26. Salvi S., Fontana V., Boccardo S., Merlo D. F., Margallo E., Laurent S., Morabito A., Rijavec E., Dal Bello M. G., Mora M., Ratto G. B., Grossi F., Truini M., Pistillo M. P., Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. Cancer Immunology, Immunotherapy 2012 61 9 1463 1472 2-s2.0-84856578692 10.1007/s00262-012-1211-y
27. Sun T., Zhou Y., Yang M., Hu Z., Tan W., Han X., Shi Y., Yao J., Guo Y., Yu D., Tian T., Zhou X., Shen H., Lin D., Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Research 2008 68 17 7025 7034 2-s2.0-52049117144 10.1158/0008-5472.CAN- 08-0806
28. Ghaderi A., Yeganeh F., Kalantari T., Talei A. R., Mohammad Pezeshki A., Doroudchi M., Dehaghani A. S., Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Research and Treatment 2004 86 1 1 7 2-s2.0-3142669785 10.1023/B:BREA.0000032918.89120.8e (Pubitemid 38918893)
29. Hadinia A., Hossieni S. V., Erfani N., Saberi-Firozi M., Fattahi M. J., Ghaderi A., CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. Journal of Gastroenterology and Hepatology 2007 22 12 2283 2287 2-s2.0-36348998540 10.1111/j.1440-1746.2007.04862.x (Pubitemid 350145629)
30. Qi P., Ruan C.-P., Wang H., Zhou F.-G., Xu X.-Y., Gu X., Zhao Y.-P., Dou T.-H., Gao C.-F., CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. International Journal of Colorectal Disease 2010 25 1 39 45 2-s2.0-72349091792 10.1007/s00384-009- 0806-z
31. Wong Y.-K., Chang K.-W., Cheng C.-Y., Liu C.-J., Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2006 35 1 51 54 2-s2.0-33645215414 10.1111/j.1600-0714.2005.00377.x
32. Wang L., Li D., Fu Z., Li H., Jiang W., Li D., Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC cancer 2007 7 article 173 2-s2.0-36048939615 c
33. Pawlak E., Karabon L., Wlodarska-Polinska I., Jedynak A., Jonkisz A., Tomkiewicz A., Kornafel J., Stepien M., Ignatowicz A., Lebioda A., Dobosz T., Frydecka I., Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Human Immunology 2010 71 2 195 200 2-s2.0-74449089797 10.1016/j.humimm.2009.11.006
34. Su T.-H., Chang T.-Y., Lee Y.-J., Chen C.-K., Liu H.-F., Chu C.-C., Lin M., Wang P.-T., Huang W.-C., Chen T.-C., Yang Y.-C., CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 2007 28 6 1237 1240 2-s2.0-34447325917 10.1093/carcin/bgm043 (Pubitemid 47062682)
35. Suwalska K., Pawlak E., Karabon L., Tomkiewicz A., Dobosz T., Urbaniak-Kujda D., Kuliczkowski K., Wolowiec D., Jedynak A., Frydecka I., Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population. Human Immunology 2008 69 3 193 201 2-s2.0-41549148099 10.1016/j.humimm.2008.01.014
36. Dilmec F., Ozgonul A., Uzunkoy A., Akkafa F., Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. International Journal of Immunogenetics 2008 35 4-5 317 321 2-s2.0-52649140419 10.1111/j.1744-313X.2008.00782.x
37. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.-C., Polychronakos C., A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry 2002 277 48 46478 46486 2-s2.0-2242465734 10.1074/jbc.M206894200 (Pubitemid 35417644)
38. Kouki T., Sawai Y., Gardine C. A., Fisfalen M.-E., Alegre M.-L., DeGroot L. J., CTLA-4 Gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology 2000 165 11 6606 6611 2-s2.0-0034548720
39. Song B., Liu Y., Liu J., Song X., Wang Z., Wang M., Zhu Y., Han J., CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration 2011 82 5 439 444 2-s2.0-81155160898 10.1159/000329345
40. Høgdall E. V. S., Kjaer S. K., Glud E., Christensen L., Blaakaer J., Vuust J., Bock J. E., Norgaard-Pedersen B., Hogdall C. K., Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "malova" ovarian cancer study. Anticancer Research 2003 23 4 3397 3404 2-s2.0-0043029872 (Pubitemid 36975440)
41. Chistiakov D. A., Savost'anov K. V., Turakulov R. I., Efremov I. A., Demurov L. M., Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clinical Immunology 2006 118 2-3 233 242 2-s2.0-32144456238 10.1016/j.clim.2005.09.017 (Pubitemid 43204318)
42. Anjos S. M., Tessier M.-C., Polychronakos C., Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. Journal of Clinical Endocrinology and Metabolism 2004 89 12 6257 6265 2-s2.0-10344224011 10.1210/jc.2004-0881 (Pubitemid 39628442)
43. Wang X. B., Zhao X., Giscombe R., Lefvert A. K., A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes and Immunity 2002 3 4 233 234 2-s2.0-0036615259 10.1038/sj.gene.6363869 (Pubitemid 38961137)
44. Ligers A., Teleshova N., Masterman T., Huang W.-X., Hillert J., CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and Immunity 2001 2 3 145 152 2-s2.0-0035346140 10.1038/sj.gene.6363752 (Pubitemid 33674879)
45. Khaghanzadeh N., Erfani N., Ghayumi M. A., Ghaderi A., CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer Genetics and Cytogenetics 2010 196 2 171 174 2-s2.0-71649104713 10.1016/j.cancergencyto.2009. 09.001